FDA Inspection 1190642 — Allan Lund, MD
The FDA completed an inspection of Allan Lund, MD on November 3, 2022 in Copenhagen O. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 3, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Copenhagen O (Denmark)
Additional Details
Clinical Investigator (CI)